They are pseudo progession in the treatment cohorts. In the placebo, some did real progession then they crossed over. They got the vaccines and DCVax-L helped extend their lives. I believe those treatment patients who got early reaped the most reward of efficacy from the vaccines. I believe FDA knew this. Some said FDA was not blinded like most of us. I believe if those pseudo were adjudicated, PFS end point will be met. My believe is that if PFS end point fails, Overall Survivals end point will also fail. This is math axiom. But we know I believe OS is fat and long in treatment cohort, so PFS must be as good as OS.
I believe in this math.
All my opinion.
News 
Market Data 
Discover 
AI
